🇺🇸 FDA
Patent

US 6955895

Thymic stromal lymphopoietin receptor molecules and uses thereof

expired A61KA61K38/00

Quick answer

US patent 6955895 (Thymic stromal lymphopoietin receptor molecules and uses thereof) held by THE GOVERNMENT OF THE UNITED STATES OF AMERICA expires Mon Oct 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
THE GOVERNMENT OF THE UNITED STATES OF AMERICA
Grant date
Tue Oct 18 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/00